Mining the plasma proteome for cancer biomarkers

[1]  David E. Misek,et al.  Integral Protein Microarrays for the Identification of Lung Cancer Antigens in Sera That Induce a Humoral Immune Response*S , 2008, Molecular & Cellular Proteomics.

[2]  David E. Misek,et al.  Identification of 14-3-3θ as an antigen that induces a humoral response in lung cancer , 2007 .

[3]  E. Diamandis,et al.  Proteomics Analysis of Conditioned Media from Three Breast Cancer Cell Lines , 2007, Molecular & Cellular Proteomics.

[4]  Gil Mor,et al.  Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays , 2007, Proceedings of the National Academy of Sciences.

[5]  H. Iwata,et al.  High-throughput immunophenotyping by surface plasmon resonance imaging. , 2007, Analytical chemistry.

[6]  R. Aebersold,et al.  High Sensitivity Detection of Plasma Proteins by Multiple Reaction Monitoring of N-Glycosites*S , 2007, Molecular & Cellular Proteomics.

[7]  Veronika A. Glukhova,et al.  Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. , 2007, Journal of proteome research.

[8]  M. Mann,et al.  Is Proteomics the New Genomics? , 2007, Cell.

[9]  Navdeep Jaitly,et al.  Accurate mass measurements in proteomics. , 2007, Chemical reviews.

[10]  R. Lotan,et al.  Proteomics-based identification of proteins secreted in apical surface fluid of squamous metaplastic human tracheobronchial epithelial cells cultured by three-dimensional organotypic air-liquid interface method. , 2007, Cancer research.

[11]  Stephen Naylor,et al.  Mapping the human plasma proteome by SCX-LC-IMS-MS , 2007, Journal of the American Society for Mass Spectrometry.

[12]  L. Chin,et al.  Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers , 2007, Nature.

[13]  R. Gray,et al.  Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study. , 2007, Journal of the National Cancer Institute.

[14]  R. Philip,et al.  Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: potential theranostic approach to cancer. , 2007, Journal of proteome research.

[15]  S. Manalis,et al.  Weighing of biomolecules, single cells and single nanoparticles in fluid , 2007, Nature.

[16]  Y. Mechref,et al.  Alterations in the serum glycome due to metastatic prostate cancer. , 2007, Journal of proteome research.

[17]  R. Dwek,et al.  Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. , 2007, Glycobiology.

[18]  A. Partin,et al.  Antibody array profiling reveals serum TSP‐1 as a marker to distinguish benign from malignant prostatic disease , 2007, The Prostate.

[19]  Noriaki Ohuchi,et al.  In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. , 2007, Cancer research.

[20]  Tadashi Kondo,et al.  Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma , 2007, Clinical Cancer Research.

[21]  D. Simeone,et al.  N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. , 2007, Journal of proteome research.

[22]  R. Aebersold,et al.  Comparison of Pancreas Juice Proteins from Cancer Versus Pancreatitis Using Quantitative Proteomic Analysis , 2007, Pancreas.

[23]  Kit S. Lam,et al.  A Serum Glycomics Approach to Breast Cancer Biomarkers*S , 2007, Molecular & Cellular Proteomics.

[24]  D. T. Wong,et al.  Human body fluid proteome analysis , 2006, Proteomics.

[25]  P. Tempst,et al.  Serum Peptidome Patterns That Distinguish Metastatic Thyroid Carcinoma from Cancer-free Controls Are Unbiased by Gender and Age*S , 2006, Molecular & Cellular Proteomics.

[26]  Hailing Lu,et al.  The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens. , 2006, Cancer research.

[27]  E. Petricoin,et al.  Dynamic Profiling of the Post-translational Modifications and Interaction Partners of Epidermal Growth Factor Receptor Signaling after Stimulation by Epidermal Growth Factor Using Extended Range Proteomic Analysis (ERPA)*S , 2006, Molecular & Cellular Proteomics.

[28]  K. Trinkaus,et al.  Proteins associated with disease and clinical course in pancreas cancer: a proteomic analysis of plasma in surgical patients. , 2006, Journal of proteome research.

[29]  W. Hancock,et al.  Approaches to the study of N-linked glycoproteins in human plasma using lectin affinity chromatography and nano-HPLC coupled to electrospray linear ion trap--Fourier transform mass spectrometry. , 2006, Glycobiology.

[30]  S. Hanash,et al.  Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera. , 2006, Gastroenterology.

[31]  S. Kingsmore.  Multiplexed protein measurement: technologies and applications of protein and antibody arrays , 2006, Nature Reviews Drug Discovery.

[32]  S. Hanash,et al.  Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study , 2006, Nature Biotechnology.

[33]  Gerard Tromp,et al.  Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. , 2006, Cancer research.

[34]  W. Hancock,et al.  Monitoring of Glycoprotein Products in Cell Culture Lysates Using Lectin Affinity Chromatography and Capillary HPLC Coupled to Electrospray Linear Ion Trap‐Fourier Transform Mass Spectrometry (LTQ/FTMS) , 2006, Biotechnology progress.

[35]  J. Weinstein,et al.  Biomarkers in Cancer Staging, Prognosis and Treatment Selection , 2005, Nature Reviews Cancer.

[36]  Ruedi Aebersold,et al.  Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. , 2005, Gastroenterology.

[37]  Debashis Ghosh,et al.  Autoantibody signatures in prostate cancer. , 2005, The New England journal of medicine.

[38]  A. Rustgi,et al.  Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. , 2005, Journal of proteome research.

[39]  David E. Misek,et al.  Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis , 2005, BMC Cancer.

[40]  D. Ransohoff.  Bias as a threat to the validity of cancer molecular-marker research , 2005, Nature reviews. Cancer.

[41]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[42]  J. Shabanowitz,et al.  Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Werner Zolg,et al.  Quantification of C‐reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C‐labeled peptide standards , 2004, Proteomics.

[44]  J. Potter,et al.  A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. , 2003, Biostatistics.

[45]  Bertrand Tavitian,et al.  Nucleic acid aptamers in cancer medicine , 2002, FEBS letters.

[46]  U. Landegren,et al.  Protein detection using proximity-dependent DNA ligation assays , 2002, Nature Biotechnology.

[47]  S M Hanash,et al.  An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  F. Hoppe-Seyler,et al.  Peptide aptamers: powerful new tools for molecular medicine , 2000, Journal of Molecular Medicine.